Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post Transplant Complications

Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors

Abstract

Chronic renal failure is an acknowledged late complication of BMT. It is related to the intensive chemotherapy, radiation and supporting medications. Polymorphism in the angiotensin converting enzyme (ACE) gene is associated with progression of nephropathy caused by diabetes and IgA nephropathy. We sought to determine whether ACE genotype and other clinical factors were associated with loss of renal function after BMT. We determined the genotype of 106 adult allogeneic BMT recipients, who received a similar preparative regimen, survived 1 year, and had assessment of renal function up to 3 years after BMT. We found that the distribution of genotypes was similar to the general population; 29%, 51%, and 20% for the DD, DI, and II genotypes, respectively. There was no statistical difference in patient survival between the three groups. Among all patients, the average creatinine clearance declined from 124 (95% CI 117, 131) to 89 (95% CI 78, 100) ml/min over the 36 months after BMT. Decline in renal function over time was less for patients with the DD compared to the II genotype (P = 0.040). Renal function in patients with the DD genotype was also better than those with the DI genotype, but this was of borderline statistical significance (P = 0.055). Renal shielding reduced decline in renal function compared to no shielding (P = 0.026). We conclude that the ACE genotype does not seem to influence survival, but the DD genotype may be protective against renal injury after BMT. Furthermore, we confirm that renal shielding during TBI reduces the renal injury after BMT. Bone Marrow Transplantation (2001) 27, 451–456.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Cohen EP . Radiation nephropathy after bone marrow transplantation Kidney Int 2000 58: 903–918

    Article  CAS  Google Scholar 

  2. Lawton CA, Cohen EP, Barber-Derus SW et al. Late renal dysfunction in adult survivors of bone marrow transplantation Cancer 1991 67: 2795–2800

    Article  CAS  Google Scholar 

  3. Cohen EP, Lawton CA, Moulder JE . Bone marrow transplant nephropathy: radiation nephritis revisited Nephron 1995 70: 217–222

    Article  CAS  Google Scholar 

  4. Moulder JE, Fish BL, Cohen EP . Treatment of radiation nephropathy with ACE inhibitors Int J Radiat Oncol Biol Phys 1993 27: 93–99

    Article  CAS  Google Scholar 

  5. Moulder JE, Fish BL, Cohen EP . Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy Int J Radiat Biol 1998 73: 415–421

    Article  CAS  Google Scholar 

  6. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 1990 86: 1343–1346

    Article  CAS  Google Scholar 

  7. Navis G, van der Kleij FG, de Zeeuw D, de Jong PE . Angiotensin-converting enzyme gene I/D polymorphism and renal disease J Mol Med 1999 77: 781–791

    Article  CAS  Google Scholar 

  8. Cockcroft DW, Gault MH . Prediction of creatinine clearance from serum creatinine Nephron 1976 16: 31–41

    Article  CAS  Google Scholar 

  9. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease New Engl J Med 1995 332: 706–711

    Article  CAS  Google Scholar 

  10. Shanmugam V, Sell KW, Saha BK . Mistyping ACE heterozygotes PCR Meth Appl 1993 3: 120–121

    Article  CAS  Google Scholar 

  11. Ash RC, Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors New Engl J Med 1990 322: 485–494

    Article  CAS  Google Scholar 

  12. Lawton CA, Cohen EP, Murray KJ et al. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation Bone Marrow Transplant 1997 20: 1069–1074

    Article  CAS  Google Scholar 

  13. Kawanishi Y, Passweg J, Drobyski WR et al. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation Bone Marrow Transplant 1997 19: 1069–1077

    Article  CAS  Google Scholar 

  14. Kaplan EL, Meier P . Nonparametric estimation for incomplete observation J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  15. Rothman KJ . Estimation of confidence limits for the cumulative probability of survival in life table analysis J Chronic Dis 1978 31: 557–560

    Article  CAS  Google Scholar 

  16. Barley J, Blackwood A, Carter ND et al. Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin J Hypertens 1994 12: 955–957

    Article  CAS  Google Scholar 

  17. Zager RA . Acute renal failure in the setting of bone marrow transplantation Kidney Int 1994 46: 1443–1458

    Article  CAS  Google Scholar 

  18. Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE . End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD Nephron 1998 79: 408–412

    Article  CAS  Google Scholar 

  19. Mizuiri S, Yoshikawa H, Tanegashima M et al. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy Am J Kidney Dis 1998 31: 301–307

    Article  CAS  Google Scholar 

  20. Schachter F, Faure-Delanef L, Guenot F et al. Genetic associations with human longevity at the APOE and ACE loci Nat Genet 1994 6: 29–32

    Article  CAS  Google Scholar 

  21. Williams AG, Rayson MP, Jubb M et al. The ACE gene and muscle performance Nature 2000 403: 614

    Article  CAS  Google Scholar 

  22. Montgomery H, Clarkson P, Barnard M et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training Lancet 1999 353: 541–545

    Article  CAS  Google Scholar 

  23. Marre M, Jeunemaitre X, Gallois Y et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependentdiabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group J Clin Invest 1997 99: 1585–1595

    Article  CAS  Google Scholar 

  24. Pei Y, Scholey J, Thai K et al. Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients J Clin Invest 1997 100: 814–820

    Article  CAS  Google Scholar 

  25. Baboolal K, Ravine D, Daniels J et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease Kidney Int 1997 52: 607–613

    Article  CAS  Google Scholar 

  26. Penno G, Chaturvedi N, Talmud PJ et al. Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients Diabetes 1998 47: 1507–1511

    Article  CAS  Google Scholar 

  27. Moriyama T, Kitamura H, Ochi S et al. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria J Am Soc Nephrol 1995 6: 1676–1678

    CAS  PubMed  Google Scholar 

  28. van der Kleij FG, Schmidt A, Navis GJ et al. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status Kidney Int 1997 63: (Suppl.) S23–S26

    CAS  Google Scholar 

  29. Cohen EP, Fish BL, Moulder JE . Angiotensin II infusion exacerbates radiation nephropathy J Lab Clin Med 1999 134: 283–291

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NCI grant CA 68102-01 (MJ) and CA24652 (JM).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juckett, M., Cohen, E., Keever-Taylor, C. et al. Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors. Bone Marrow Transplant 27, 451–456 (2001). https://doi.org/10.1038/sj.bmt.1702797

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702797

Keywords

This article is cited by

Search

Quick links